Brinker Capital Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.46M | Buy |
|
|||||
|
2025
Q2 | $1.41M | Buy |
|
|||||
|
2025
Q1 | $1.04M | Buy |
|
|||||
|
2024
Q4 | $881K | Buy |
|
|||||
|
2024
Q3 | $974K | Buy |
|
|||||
|
2024
Q2 | $749K | Buy |
|
|||||
|
2024
Q1 | $321K | Sell |
|
|||||
|
2023
Q4 | $498K | Sell |
|
|||||
|
2023
Q3 | $458K | Buy |
|
|||||
|
2023
Q2 | $447K | Sell |
|
|||||
|
2023
Q1 | $498K | Sell |
|
|||||
|
2022
Q4 | $597K | Sell |
|
|||||
|
2022
Q3 | $531K | Buy |
|
|||||
|
2022
Q2 | $364K | Sell |
|
|||||
|
2022
Q1 | $453K | Sell |
|
|||||
|
2021
Q4 | $479K | Buy |
|
|||||
|
2021
Q3 | $419K | Hold |
|
|||||
|
2021
Q2 | $419K | Buy |
|
|||||
|
2021
Q1 | $270K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $69K | Hold |
|
|||||
|
2019
Q3 | $48K | Hold |
|
|||||
|
2019
Q2 | $44K | Hold |
|
|||||
|
2019
Q1 | $56K | Sell |
|
|||||
|
2018
Q4 | $83K | Hold |
|
|||||
|
2018
Q3 | $100K | Hold |
|
|||||
|
2018
Q2 | $112K | Hold |
|
|||||
|
2018
Q1 | $136K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $4K | Buy |
|